Results 11 to 20 of about 215,305 (295)

Trisubstituted pyrazolopyrimidines as novel angiogenesis inhibitors. [PDF]

open access: yesPLoS ONE, 2013
Current inhibitors of angiogenesis comprise either therapeutic antibodies (e.g. bevacicumab binding to VEGF-A) or small molecular inhibitors of receptor tyrosin kinases like e.g. sunitinib, which inhibits PDGFR and VEGFR.
Sabine B Weitensteiner   +8 more
doaj   +4 more sources

Endogenous inhibitors of angiogenesis [PDF]

open access: yesJournal of Cell Science, 2001
In the course of embryonic development, during some normal physiological processes in the adult, such as the female reproductive cycle, and also in a variety of pathologies, including tumour growth, new blood vessels develop from the pre-existing vascular network through endothelial cell sprouting,
Ruhrberg, C
openaire   +5 more sources

Endogenous Matrix-Derived Inhibitors of Angiogenesis [PDF]

open access: yesPharmaceuticals, 2010
Endogenous inhibitors of angiogenesis are proteins or fragments of proteins that are formed in the body, which can inhibit the angiogenic process. These molecules can be found both in the circulation and sequestered in the extracellular matrix (ECM ...
Hans Petter Eikesdal   +2 more
doaj   +2 more sources

Angiogenesis: Antiangiogenesis Strategy and Angiogenesis Inhibitors [PDF]

open access: yes, 2010
Angiogenesis is the development of new blood vessels from preexisting vasculature. The angiogenic process is controlled by the net balance between molecules with positive and negative regulatory activity. In the past three decades, the understanding of the fundamental role of angiogenesis in tumor growth, progression and metastasis has led to ...
null Theodora Kerenidi   +1 more
openaire   +3 more sources

Marine-Derived Angiogenesis Inhibitors for Cancer Therapy [PDF]

open access: yesMarine Drugs, 2013
Angiogenesis inhibitors have been successfully used for cancer therapy in the clinic. Many marine-derived natural products and their analogues have been reported to show antiangiogenic activities.
Ying-Qing Wang, Ze-Hong Miao
doaj   +2 more sources

Angiogenesis: signaling pathways and their inhibitors [PDF]

open access: yesМедицинская иммунология, 2019
Angiogenesis refers to the formation of new blood vessels from existing ones and is considered a crucial stage in vascular development. Two distinct types of angiogenesis have been identified: branching and non-branching angiogenesis.
Ksenia L. Markova   +4 more
doaj   +3 more sources

Research Advances of PD-1/PD-L1 Inhibitors Combined with Angiogenesis Inhibitors in Treatment of Advanced Triple-negative Breast Cancer

open access: yesZhongliu Fangzhi Yanjiu, 2021
Advanced triple-negative breast cancer(TNBC) has less treatments, shorter survival time and poorer prognosis than other subtypes of breast cancer. The rapid development of immunotherapy in recent years is expected to prolong the survival time of advanced
HUANG Shifen, LING Xiaoling
doaj   +1 more source

Study of endostatin, tumstatin and PEDF, the natural angiogenesis inhibitors, potential in avasculargenic therapy

open access: yesOftalʹmologiâ, 2014
Purpose: To evaluate the potential of endostatin, tumstatin and PEDF in avasculargenic therapy.Methods: The avasculargenic potential of the natural angiogenesis inhibitors was explored on the model of alkaline burn, attended with angiogenesis of cornea ...
V. G. Likhvantseva   +8 more
doaj   +3 more sources

The Vasohibin Family

open access: yesPharmaceuticals, 2010
Angiogenesis is regulated by the local balance between angiogenesis stimulators and inhibitors. A number of endogenous angiogenesis inhibitors have been found in the body. The origin of these inhibitors is mostly extrinsic to the vasculature.
Yasufumi Sato
doaj   +1 more source

Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma

open access: yesIJU Case Reports, 2020
Introduction Nivolumab is effective for advanced renal cell carcinoma; however, reports are limited wherein nivolumab is combined with sequential therapy of angiogenesis inhibitors and metastasectomy.
Hiroki Hagimoto   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy